Latest Period
Q1 2026
Security Snapshot
Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) Institutional Ownership
CUSIP: 45783C101
13F Institutional Holders and Ownership History from Q1 2021 to Q1 2026
Institutions Reporting
1
Shares (Excl. Options)
1,899,004
Price
$8.24
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, $0.000001 par value per share
- Symbol
- TIL on Nasdaq
- Shares outstanding
- 6,795,789
- Price per share
- $8.24
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 1,899,004
- Total reported value
- $15,647,793
- Share change
- 0
- Number of holders
- 1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- TIL - Instil Bio, Inc. - Common Stock, $0.000001 par value per share is tracked under CUSIP 45783C101.
- 1 institution reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 1 to 1 between Q4 2025 and Q1 2026.
- Reported value moved from $20,889,044 to $15,647,793.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 1 institution filings for Q1 2026.
Security key
45783C101
Latest holder period
Q1 2026
13F holders
1
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
TIL full holder history
Instil Bio, Inc. SEC filings
Instil Bio, Inc. company facts
Instil Bio, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45783C101:
Significant Owners of Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BML Investment Partners, L.P. | 9.5% | +40% | +$2,261,600 | 645,600 | +47% | BML Investment Partners, L.P. | 31 Dec 2025 |
As of 31 Mar 2026, 1 institutional investors reported holding 1,899,004 shares of Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL). This represents 28% of the company’s total 6,795,789 outstanding shares.
Top 1 Institutional Shareholders
The largest institutional shareholders of Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) together control 28% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Curative Ventures V LLC | 28% | 1,899,004 | 0% | 100% | $15,647,793 |
Institutional Holders of Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 1,899,004 | $15,647,793 | $8.24 | 1 | |
| 2025 Q4 | 1,899,004 | $20,889,044 | $11.00 | 1 | |
| 2025 Q3 | 1,899,004 | $33,916,211 | $17.86 | 1 | |
| 2025 Q2 | 1,899,004 | $39,556,253 | $20.83 | 1 | |
| 2025 Q1 | 1,899,004 | $32,966,709 | $17.36 | 1 | |
| 2024 Q4 | 1,899,004 | $36,251,986 | $19.09 | 1 | |
| 2024 Q3 | 1,899,004 | $127,840,949 | $67.32 | 1 | |
| 2024 Q2 | 1,899,004 | $19,540,751 | $10.29 | 1 | |
| 2024 Q1 | 1,899,004 | $20,509,243 | $10.80 | 1 | |
| 2023 Q4 | 1,899,004 | $14,470,411 | -$293,013,435 | $7.62 | 1 |
| 2023 Q3 | 80,213,679 | $34,331,150 | -$1,109,021 | $0.43 | 55 |
| 2023 Q2 | 82,147,379 | $45,260,450 | -$5,605,875 | $0.55 | 59 |
| 2023 Q1 | 92,130,450 | $60,884,962 | -$6,260,427 | $0.66 | 71 |
| 2022 Q4 | 101,672,812 | $64,055,715 | -$83,583,995 | $0.63 | 74 |
| 2022 Q3 | 119,246,716 | $577,157,799 | +$157,556 | $4.84 | 87 |
| 2022 Q2 | 119,227,879 | $550,824,336 | -$14,427,751 | $4.62 | 91 |
| 2022 Q1 | 79,945,385 | $859,413,492 | +$16,751,395 | $10.75 | 74 |
| 2021 Q4 | 78,059,347 | $1,335,498,956 | +$128,543,404 | $17.11 | 74 |
| 2021 Q3 | 71,872,127 | $1,284,834,308 | +$23,155,961 | $17.88 | 64 |
| 2021 Q2 | 69,297,488 | $1,333,870,574 | +$94,985,160 | $19.32 | 61 |
| 2021 Q1 | 65,033,804 | $1,617,866,000 | +$1,617,866,001 | $25.08 | 56 |